Tricuspid Regurgitation Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT01093001

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
  • Mayo Clinic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01093001
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01093001. Randomized; no masking; primary purpose prevention. Start 2010-05 (registry gives no type); primary completion 2015-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tricuspid Regurgitation Study
Condition
Tricuspid Regurgitation
Condition
Right Ventricular Dysfunction
Condition
Left Ventricular Dysfunction
Intervention (Other)
Echo
Intervention (Other)
Echo
Intervention (Other)
Echo
Intervention (Other)
Echo
Lead sponsor
Mayo Clinic (class: other)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01093001
Content hash
442d00178bd2f24e25bd3d64e02ef9ede1735959e2f6018c221469dfa2a9078b